Supernus Pharmaceuticals, Inc. (SUPN)

Supernus Pharmaceuticals Revenue

In the year 2024, Supernus Pharmaceuticals had annual revenue of $661.82M with 8.94% growth. Supernus Pharmaceuticals had revenue of $174.16M in the quarter ending December 31, 2024, with 5.99% growth.

• Revenue (ttm): $661.82M
• Revenue Growth: +8.94%
• P/S Ratio: 2.66
• Revenue / Employee: $1,015,057
• Employees: 652
• Market Cap: 1.79B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	661.82M	54.30M	8.94%
Dec 31, 2023	607.52M	-59.72M	-8.95%
Dec 31, 2022	667.24M	87.46M	15.09%
Dec 31, 2021	579.78M	59.38M	11.41%
Dec 31, 2020	520.40M	127.64M	32.50%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.